CLASS II Device recall · Reported 12 Jan 2022 · FDA Enforcement Report

QIAstat-Dx Respiratory Sars-CoV-2 Panel recalled by Qiagen Sciences

Qiagen Sciences is recalling QIAstat-Dx Respiratory Sars-CoV-2 Panel (US IVD under FDA EUA 200075), distributed in 8 states. The recall was initiated on 8 Nov 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLOT 210209 UDI (01)14053228038846(17)211127(10)210209(24)691223 Serial Numbers: 412092551 412092559 412092552 412092560 412092553 412092561 412092554 412092563 412092555 412092564 412092556 412092565 412092557 412092566 412092558 412092567
Quantity recalled376 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0455-2022
FDA event ID
89130
Recalling firm
Qiagen Sciences, Germantown, MD
Classification
Class II
Status
Terminated
Recall initiated
8 Nov 2021
FDA classified
5 Jan 2022
Reported
12 Jan 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

8 Nov 2021Recall initiated by company
5 Jan 2022Classified by FDA+58 days
12 Jan 2022Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The firm identified sixteen (16) faulty cartridges in LOT 210209, which contain incorrect primer-probe mixes in the reaction chambers. If an affected cartridge is used, false-negative, false-positive, or both false-negative and false-positive results could occur.

Product as listed by the FDA

QIAstat-Dx Respiratory SARS-CoV-2 Panel (US IVD under FDA EUA 200075); REF 691223

Where it was distributed

Domestic distribution to AL, DC, KY, MD, ME, NJ, OK< PA, and TX. No foreign distribution.

AlabamaDistrict of ColumbiaKentuckyMarylandMaineNew JerseyPennsylvaniaTexas

Questions about this recall

Why was it recalled?

The firm identified sixteen (16) faulty cartridges in LOT 210209, which contain incorrect primer-probe mixes in the reaction chambers. If an affected cartridge is used, false-negative, false-positive, or both false-negative and false-positive results could occur.

Which lots are affected?

LOT 210209 UDI (01)14053228038846(17)211127(10)210209(24)691223 Serial Numbers: 412092551 412092559 412092552 412092560 412092553 412092561 412092554 412092563 412092555 412092564 412092556 412092565 412092557 412092566 412092558 412092567

Where was it sold?

Domestic distribution to AL, DC, KY, MD, ME, NJ, OK< PA, and TX. No foreign distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Qiagen Sciences

All 23

Other CPAP & Ventilators recalls

All 568